Degroot Foot & Ankle Clinic, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1938 E Lincoln Hwy, Suite 206, New Lenox, IL 60451 Phone: 815-462-9225 Fax: 815-462-5385 |
Dr. Kyle Kirchner, DPM Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 250 E Maple St, New Lenox, IL 60451 Phone: 815-485-5830 Fax: 815-485-8531 |
Kirchner Foot & Ankle Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 250 E Maple St, New Lenox, IL 60451 Phone: 815-485-5830 Fax: 815-485-8531 |
Dr. Mary D Degroot, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1938 E Lincoln Hwy, Suite 206, New Lenox, IL 60451 Phone: 815-462-9225 Fax: 815-462-5385 |
Dr. Michael Aubrey Shanholtzer, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 500 W Maple St, Suite 206, New Lenox, IL 60451 Phone: 815-485-3369 Fax: 815-485-4925 |
Paul Bernard Kirchner, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 250 E Maple St, New Lenox, IL 60451 Phone: 815-485-0760 Fax: 815-463-6138 |
Chicagoland Foot And Ankle, Pc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1938 E Lincoln Hwy, Ste 206, New Lenox, IL 60451 Phone: 815-462-9225 Fax: 815-717-6565 |
News Archive
NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.
The oral calcimimetic agent, cinacalcet, has been found to have no significant effect on cardiovascular events or death in patients with chronic kidney disease in a randomized controlled trial.
HHS announced Tuesday that it "has begun accepting applications for the early retiree reinsurance program created by the new health law. The law sets aside $5 billion that businesses, unions and state and local governments can use to cover the healthcare costs of their retirees — and their spouses and dependents — who are older than 55 but don't yet qualify for Medicare." Some are worried that money for that program won't last through 2014, when other parts of the law take effect.
Following a successful research collaboration with NJIT, Catalent Pharma Solutions of Somerset has announced that it has exclusively licensed innovative taste-making technology developed by NJIT Distinguished Professor Rajesh Dav-, who was the principal investigator of a research project funded by Catalent. The technology will mask the most challenging, unpleasant and bitter tasting pharmaceutical active ingredients.
› Verified 6 days ago